US-listed company Sonnet BioTherapeutics postpones merger vote to December 2
Show original
Foresight News reported that the US-listed company Sonnet BioTherapeutics has postponed its merger vote to December 2. Previously, it was reported that Sonnet BioTherapeutics would merge with Rorschach I LLC to form Hyperliquid Strategies and advance the HYPE reserve strategy.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Trending news
MoreCrypto prices
MoreBitcoin
BTC
$85,916.65
+2.57%
Ethereum
ETH
$2,808.68
+3.50%
Tether USDt
USDT
$0.9994
-0.00%
XRP
XRP
$2.03
+6.88%
BNB
BNB
$841.1
+2.36%
USDC
USDC
$0.9997
-0.02%
Solana
SOL
$129.71
+3.05%
TRON
TRX
$0.2746
+0.28%
Dogecoin
DOGE
$0.1439
+5.21%
Cardano
ADA
$0.4089
+2.55%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now